NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2022 and provides a business update. Financial results for the first nine months of 2022 include DERMAdoctor, which NovaBay acquired on November 5, 2021. “Revenues grew an impressive 69% as we benefitted from the DERMAdoctor acquisition and our expanded product portfolio. Highlights of the quarter include the most DERMAdoctor produc